scPharmaceuticals, Inc. (SCPH): Narx/daromad koeffitsiyenti

scPharma (SCPH) brendining ramzi va logotipi

scPharmaceuticals Inc. (SCPH) pul oqimlari furosemid yetkazib berish tizimlari uchun patentlar va FDA ning qat'iy nazorati bilan himoyalangan. Kompaniyaning sotuvlarga nisbatan narx koeffitsiyenti ushbu tendentsiyani aniq tasdiqlaydi, bunda 6.00 qiymati joriy ko'rsatkichni ifodalaydi. Global o'sishning yuqori salohiyati intellektual mulkka asoslangan bo'lsa-da, moliyaviy barqarorlik hozirda faqatgina yagona flagman mahsulotning muvaffaqiyatiga bog'liq.

SCPH scpharmaceuticals.com: Narxning daromadga nisbati 21.05.2023 - 18.10.2025 oraligʻida

scPharmaceuticals Inc. (SCPH) kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Narxlar dinamikasi grafigi scpharmaceuticals.com|SCPH - Maqsadli narxlar grafigi
- birja kapitallashuvi ma'lumotlari:
Bozor kapitallashuvi scPharma|SCPH - Korxona qiymati
- kompaniyaning balans qiymati tafsilotlari:
Bitta aksiya uchun buxgalteriya qiymati scPharmaceuticals|SCPH - Kompaniyaning balans qiymati|Sof aktivlarga nisbatan bozor kapitallashuvi scpharmaceuticals.com|SCPH - Kompaniyaning umumiy aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati scPharmaceuticals Inc.|SCPH - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati scpharmaceuticals.com|SCPH - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati scPharma|SCPH - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari scPharmaceuticals|Tezkor likvidlik koeffitsiyenti scpharmaceuticals.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
SCPH - Sof foyda|Kelajakdagi foyda scPharmaceuticals Inc.|SCPH - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati scpharmaceuticals.com|SCPH - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori scPharma|SCPH - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda scPharmaceuticals|SCPH - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi scpharmaceuticals.com|SCPH - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi scPharmaceuticals Inc.
- umumiy tushum va sotuv hajmi ma'lumotlari:
SCPH - Daromad va sotish hajmi|Prognoz qilingan sotish hajmi scpharmaceuticals.com|SCPH - Narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati scPharma
Kompaniyaning fundamental tahlili:scPharmaceuticals, Inc., SCPH
scPharmaceuticals Inc. tayyor mahsulotlari

Furoscix tizimi orqali yurak yetishmovchiligini uy sharoitida davolashni monetizatsiya qiluvchi scPharmaceuticals Inc. (SCPH) uchun ushbu ko'rsatkich generatsiya qilingan daromadning har bir birligining bozor qiymatini belgilaydi. P/S koeffitsiyentini tahlil qilish orqali investor bozor kapitalizatsiyasini sug'urta to'lovlaridan tushgan daromadlar bilan solishtiradi, bu esa biznesni kengaytirish salohiyati uchun to'langan premiumni va bemorlarning statsionar davolanishdan uy sharoitidagi parvarishga o'tishi fonida baholashning barqarorligini baholash imkonini beradi.

scPharmaceuticals Inc. raqobatchilari

HLN (haleon.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Kenvue KVUE|Narx/daromad koeffitsiyenti Verona Pharma PLC (VRNA)|Jyong Biotech Corp - P/S multiplikatori|Ligand Corp (LGND) - Kapitalizatsiyaning daromadga nisbati|Amneal Pharmaceuticals (AMRX) - Narxning daromadga nisbati|Narxning sotuvga nisbati PRGO (perrigo.com)|ALVO (Alvotech SA) - P/S multiplikatori|LQDA: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori GLPG|P/S multiplikatori ANI Pharmaceuticals Corp (ANIP)|Narxning daromadga nisbati MannKind Corporation MNKD|Bozor kapitallashuvining daromadga nisbati AMPH|PCRX - Narxning daromadga nisbati|ARS Pharmaceuticals Inc (SPRY) - Kapitalizatsiyaning daromadga nisbati|TBPH: P/S multiplikatori|Aquestive Corp (AQST) - P/S multiplikatori|TECX (Tectonic Therapeutic Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati tonixpharma.com (TNXP)|P/S multiplikatori SXTC|EPRX - Sotuvga nisbatan narx|BioHarvest - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Invizyne EXOZ|ORMP: Kapitalizatsiyaning daromadga nisbati|Entera Bio Ltd. - Kapitalizatsiyaning sotish hajmiga nisbati|HYFT: P/S multiplikatori|ABVC - Narx/daromad koeffitsiyenti|CPIX (Cumberland Pharma) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Quantum BioPharma Corp (QNTM)|P/S multiplikatori FGEN|P/S multiplikatori telomirpharma.com (TELO)|Narxning daromadga nisbati Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp. - Narxning daromadga nisbati|RLYB - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Lexaria Bioscience LEXX|PULM (Pulmatrix, Inc.) - Kapitalizatsiyaning daromadga nisbati|Pheton Holdings - Bozor kapitallashuvining daromadga nisbati|APM (Aptorum Group Ltd) - P/S multiplikatori|Lyra Therapeutics Inc. (LYRA) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Impact BioMedical (IBO)|tnfpharma.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori YCBD (cbdMD)|PRFX - Kapitalizatsiyaning daromadga nisbati|CYTO: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Lipella Pharmaceuticals Inc LIPO|Optinose (OPTN) - Narxning daromadga nisbati|PIRS - Narx/daromad koeffitsiyenti|PROC (Procaps Group S.A.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati petrospharma.com (PTPI)|Narxning daromadga nisbati Qilian International Holding (QLI)|SLRN: Narxning sotuvga nisbati|P/S multiplikatori TFFP (TFF Pharma)